Myron Kaplan - 18 May 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Director
Signature: /s/ Myron Kaplan
Issuer symbol: CRMD
Transactions as of: 18 May 2023
Net transactions value: +$27,258
Form type: 4
Filing time: 19 May 2023, 16:02:16 UTC
Previous filing: 18 Jan 2023
Next filing: 20 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Purchase	$27,258	+6,000	+3.7%	$4.54	166,034	18 May 2023	Direct	F1
holding	CRMD	Common Stock						20,000	18 May 2023	Spouse	F2
holding	CRMD	Common Stock						10,000	18 May 2023	Spouse as Guardian for Grandchildren	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.